Variational AI inks drug discovery deal with Merck worth up to $349-million

theglobeandmail.com/business/article-variational-ai-merck-drug-discovery-deal-349-million

Variational AI Inc., a Vancouver startup that uses generative artificial intelligence to discover therapeutic drugs, has signed a two-year development deal with Merck & Co. Inc. MRK-N that could be worth up to US$349-million.
Variational will use its Enki platform, trained on Merck data,…

This story appeared on theglobeandmail.com, 2025-09-23 11:00:00.
The Entire Business World on a Single Page. Free to Use →